IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 37,750
-1,750 (-4.43%)
At close: Apr 9, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 567.08 billion as of April 10, 2026.
Market Cap
567.08B
Enterprise Value
546.49B
Revenue
2.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
37,750.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 567.08B, an increase of 15.18%. That is a compound annual growth rate of 17.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 567.08B | -34.14% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 852.40B |
| Curocell | 813.61B |
| IMBiologics | 746.91B |
| Kanaph Therapeutics | 466.42B |
| HansBiomed | 456.36B |
| Y-Biologics | 374.14B |
| S.Biomedics | 329.44B |
| Kangstem Biotech | 303.79B |